AU8084594A - Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients - Google Patents
Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredientsInfo
- Publication number
- AU8084594A AU8084594A AU80845/94A AU8084594A AU8084594A AU 8084594 A AU8084594 A AU 8084594A AU 80845/94 A AU80845/94 A AU 80845/94A AU 8084594 A AU8084594 A AU 8084594A AU 8084594 A AU8084594 A AU 8084594A
- Authority
- AU
- Australia
- Prior art keywords
- dosage forms
- active ingredients
- aluminum silicate
- magnesium aluminum
- containing magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14459293A | 1993-10-28 | 1993-10-28 | |
US144592 | 1993-10-28 | ||
PCT/US1994/012018 WO1995011671A1 (en) | 1993-10-28 | 1994-10-20 | Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8084594A true AU8084594A (en) | 1995-05-22 |
Family
ID=22509264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU80845/94A Abandoned AU8084594A (en) | 1993-10-28 | 1994-10-20 | Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0725630A1 (de) |
JP (1) | JPH09504293A (de) |
AU (1) | AU8084594A (de) |
WO (1) | WO1995011671A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3693397A (en) * | 1996-07-10 | 1998-02-02 | Novartis Consumer Health S.A. | Oral pharmaceutical combinations of antihistaminic compounds and terpenoids |
MY119059A (en) † | 1997-08-11 | 2005-03-31 | Cadbury Adams Usa Llc | Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same |
US7588793B1 (en) | 1998-06-05 | 2009-09-15 | Cadbury Adams Usa, Llc | Enhanced flavoring compositions containing N-ethyl-p-menthane-3-carboxamide and method of making and using same |
AU767154B2 (en) * | 1998-11-20 | 2003-10-30 | Skyepharma Canada Inc. | Dispersible phospholipid stabilized microparticles |
US6391886B1 (en) * | 2000-12-04 | 2002-05-21 | The Procter & Gamble Company | Oral compositions having improved consumer aesthetics |
US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
US8097271B2 (en) | 2004-08-11 | 2012-01-17 | Kraft Foods Global Brands Llc | Warming compositions and delivery systems therefor |
US8022032B2 (en) | 2004-11-19 | 2011-09-20 | Smithkline Beecham Corporation | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
EP1973422B1 (de) | 2005-12-23 | 2014-06-11 | Intercontinental Great Brands LLC | Zusammensetzungen für die orale oder dermale abgabe, die ein wärmegefühl vermitteln |
SG173537A1 (en) | 2009-04-01 | 2011-09-29 | Colgate Palmolive Co | Dentifrice compositions and methods for treating and preventing damage to tooth surfaces |
ES2656944T3 (es) | 2011-04-29 | 2018-03-01 | Intercontinental Great Brands Llc | Ácido encapsulado, método de preparación del mismo, y goma de mascar que lo comprende |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4711774A (en) * | 1986-03-27 | 1987-12-08 | Warner-Lambert Company | Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
ATE128351T1 (de) * | 1991-04-04 | 1995-10-15 | Procter & Gamble | Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. |
WO1994020074A1 (en) * | 1993-03-12 | 1994-09-15 | The Procter & Gamble Company | Adsorbate compositions |
-
1994
- 1994-10-20 JP JP7512714A patent/JPH09504293A/ja active Pending
- 1994-10-20 WO PCT/US1994/012018 patent/WO1995011671A1/en active Search and Examination
- 1994-10-20 EP EP94931939A patent/EP0725630A1/de not_active Withdrawn
- 1994-10-20 AU AU80845/94A patent/AU8084594A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH09504293A (ja) | 1997-04-28 |
WO1995011671A1 (en) | 1995-05-04 |
EP0725630A1 (de) | 1996-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT75648A (en) | 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them | |
AU5945396A (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
HK1001860A1 (en) | I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
IL110834A0 (en) | Carboxamides, their preparation and pharmaceutical compositions containing them | |
AU3373293A (en) | Anthraquinone compounds and pharmaceutical compositions containing them | |
AU7961094A (en) | Picosulphate dosage form | |
IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
AU8084594A (en) | Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients | |
AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
GB9504040D0 (en) | Arylsulfonamide derivative and pharmaceutical composition containing the same | |
AU5643894A (en) | Novel esculetin derivatives and pharmaceutical composition | |
AU3465393A (en) | Pharmaceutic composition and its use | |
AU4513893A (en) | Sulfamoyltriazole derivative and bactericide containing the same as active ingredient | |
IL108810A0 (en) | Optical isomerization inhibitor and pharmaceutical compositions containing the same | |
AU3526193A (en) | Dosage aerosols containing the active substance flezelastin and related structures | |
AU7318994A (en) | Thf-gamma2 analogs and pharmaceutical compositions comprising them | |
NZ269990A (en) | Inhibiting hiv viruses; use of azaspirane compounds in preparation of medicaments | |
AU6345794A (en) | Ipsapirone medicament formulation | |
ZA935862B (en) | New hydrazono-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
AU6426994A (en) | Aluminium containing pharmaceutical preparation with controlled release | |
AU2875692A (en) | Easily stored pillow and blanket | |
HUT73481A (en) | Tropane-derivates having analgesic and nootropic effect and pharmaceutical compositions containing the same | |
AU7292594A (en) | Peelable barrier overwrap package | |
AU6208594A (en) | Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent | |
AU8108394A (en) | Pharmaceutical composition and use thereof |